Ofer Mandelboim

Q: What Schools Are Affiliated With Ofer Mandelboim

Ofer Mandelboim is affiliated with the following schools: Harvard University, University of Alabama, Bar-Ilan University, Weizmann Institute of Science, Hebrew University of Jerusalem, Tel Aviv University, Stanford University, Ben-Gurion University of the Negev

Ofer Mandelboim's AcademicInfluence.com Rankings

Ofer Mandelboim

Computer Science

#8762

World Rank

#9213

Historical Rank

Machine Learning

#3675

World Rank

#3721

Historical Rank

Artificial Intelligence

#3987

World Rank

#4045

Historical Rank

Database

#5762

World Rank

#5978

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Ofer Mandelboim's Degrees

PhD Computer Science Tel Aviv University
Masters Computer Science Tel Aviv University
Bachelors Computer Science Tel Aviv University

Similar Degrees You Can Earn

Why Is Ofer Mandelboim Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ofer Mandelboim's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity (2009) (3299)
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface (2006) (1485)
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells (2001) (1039)
Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. (2008) (1028)
The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. (1999) (927)
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. (2015) (723)
Host Immune System Gene Targeting by a Viral miRNA (2007) (695)
Characterization of the expression of MHC proteins in human embryonic stem cells (2002) (663)
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1 (2006) (580)
Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells (1996) (528)
Recognition of viral hemagglutinins by NKp44 but not by NKp30 (2001) (458)
Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. (2009) (452)
The human natural killer cell immune synapse. (1999) (426)
Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells (2006) (423)
Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus (2005) (405)
Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules (1996) (373)
NK cells link obesity-induced adipose stress to inflammation and insulin resistance (2015) (372)
CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells. (2003) (351)
The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells (1997) (344)
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D (2008) (330)
Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. (2013) (274)
Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. (1999) (274)
The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. (2004) (259)
Endometrial NK Cells Are Special Immature Cells That Await Pregnancy1 (2008) (222)
Human NK Cells Selective Targeting of Colon Cancer–Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules (2013) (209)
Mouse TIGIT inhibits NK‐cell cytotoxicity upon interaction with PVR (2013) (191)
CD66a Interactions Between Human Melanoma and NK Cells: A Novel Class I MHC-Independent Inhibitory Mechanism of Cytotoxicity1 (2002) (189)
Trained Memory of Human Uterine NK Cells Enhances Their Function in Subsequent Pregnancies (2018) (187)
The activating receptor NKp46 is essential for the development of type 1 diabetes (2010) (184)
The NKp46 Receptor Contributes to NK Cell Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium1 (2002) (182)
Novel APC-like properties of human NK cells directly regulate T cell activation. (2004) (181)
REVIEW ARTICLE: The Unique Properties of Uterine NK Cells (2010) (180)
Tumor and viral recognition by natural killer cells receptors. (2006) (177)
Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides (1995) (174)
Novel Insights on Human NK Cells’ Immunological Modalities Revealed by Gene Expression Profiling1 (2004) (173)
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors (2012) (169)
An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. (2011) (168)
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma (1997) (162)
CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells (2007) (159)
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression (2020) (157)
The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination (2010) (155)
Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR11 (2009) (153)
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma (1994) (145)
Complexes of HLA-G Protein on the Cell Surface Are Important for Leukocyte Ig-Like Receptor-1 Function1 (2003) (143)
NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis (2011) (142)
Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. (2002) (141)
Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1 (2012) (137)
When killers become helpers. (2007) (131)
Recruitment of MHC Class I Molecules by Tapasin into the Transporter Associated with Antigen Processing-Associated Complex Is Essential for Optimal Peptide Loading (2002) (130)
MiRNA-Mediated Control of HLA-G Expression and Function (2012) (130)
Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. (2003) (128)
Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus (2004) (126)
Recognition of HLA-Cw4 but Not HLA-Cw6 by the NK Cell Receptor Killer Cell Ig-Like Receptor Two-Domain Short Tail Number 41 (2001) (122)
Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. (2003) (120)
Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape (2017) (118)
Analysis of Human Cytomegalovirus-Encoded MicroRNA Activity during Infection (2009) (117)
MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells. (2012) (116)
The Natural Cytotoxicity Receptor NKp46 Is Dispensable for IL-22-Mediated Innate Intestinal Immune Defense against Citrobacter rodentium1 (2009) (116)
Direct Recognition of Fusobacterium nucleatum by the NK Cell Natural Cytotoxicity Receptor NKp46 Aggravates Periodontal Disease (2012) (112)
Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy. (1997) (111)
The CD85J/Leukocyte Inhibitory Receptor-1 Distinguishes between Conformed and β2-Microglobulin-Free HLA-G Molecules1 (2005) (111)
MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS41 (2004) (110)
NKp46 Receptor‐Mediated Interferon‐&ggr; Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis (2018) (110)
2B4 (CD244) Is Expressed and Functional on Human Eosinophils1 (2005) (106)
Characterization of tumor infiltrating Natural Killer cell subset (2015) (103)
Tumor Immunoediting by NKp46 (2010) (103)
Enhancement of Class II-Restricted T cell Responses by Costimulatory NK Receptors for Class I MHC Proteins (1996) (102)
The binding site of NK receptors on HLA-C molecules. (1997) (101)
NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy (2018) (95)
Human NK cells: their ligands, receptors and functions (1997) (92)
Self and viral peptides can initiate lysis by autologous natural killer cells. (1997) (92)
Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. (2004) (90)
Targeting PVR (CD155) and its receptors in anti-tumor therapy (2018) (90)
The unique properties of human NK cells in the uterine mucosa. (2008) (90)
An integrated view of the regulation of NKG2D ligands (2009) (87)
Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells. (1998) (85)
H5-Type Influenza Virus Hemagglutinin Is Functionally Recognized by the Natural Killer-Activating Receptor NKp44 (2007) (83)
Multiple receptors for HLA-G on human natural killer cells. (1997) (83)
Enhanced Recognition of Human NK Receptors After Influenza Virus Infection1 (2003) (80)
The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. (2004) (78)
Dynamic behavior of NK cells during activation in lymph nodes. (2009) (76)
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System (2020) (76)
Inhibitory NK Receptor Recognition of HLA-G: Regulation by Contact Residues and by Cell Specific Expression at the Fetal-Maternal Interface (2010) (73)
Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1 (2019) (70)
Influenza Virus Infection Augments NK Cell Inhibition through Reorganization of Major Histocompatibility Complex Class I Proteins (2008) (70)
Killing of Avian and Swine Influenza Virus by Natural Killer Cells (2010) (69)
Carcinoembryonic Antigen (CEA) Inhibits NK Killing via Interaction with CEA-Related Cell Adhesion Molecule 11 (2005) (69)
The role of microRNAs in the control of innate immune response in cancer. (2014) (68)
Neisserial Outer Membrane Vesicles Bind the Coinhibitory Receptor Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 1 and Suppress CD4+ T Lymphocyte Function (2007) (68)
Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA*008 to Escape Elimination by NK Cells (2015) (66)
Paired NK cell receptors controlling NK cytotoxicity (2010) (66)
NK Cell Recognition of Candida glabrata through Binding of NKp46 and NCR1 to Fungal Ligands Epa1, Epa6, and Epa7. (2016) (65)
Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool. (2008) (65)
Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells. (2013) (62)
Impaired spontaneous endocytosis of HLA‐G (1997) (61)
CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells (2011) (61)
Soluble nonclassical HLA generated by the metalloproteinase pathway. (2003) (60)
Recognition and Killing of Human and Murine Pancreatic β Cells by the NK Receptor NKp46 (2011) (59)
Inhibition of Human Tumor-Infiltrating Lymphocyte Effector Functions by the Homophilic Carcinoembryonic Cell Adhesion Molecule 1 Interactions1 (2006) (59)
NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis (2018) (57)
Elucidating the Mechanisms of Influenza Virus Recognition by Ncr1 (2012) (57)
The involvement of NK cells in ankylosing spondylitis. (2005) (55)
Virus-mediated inhibition of natural cytotoxicity receptor recognition (2012) (55)
Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses. (2013) (54)
Expression and Function of CD300 in NK Cells (2010) (54)
NKp46 O-Glycan Sequences That Are Involved in the Interaction with Hemagglutinin Type 1 of Influenza Virus (2010) (54)
Immune evasion by oncogenic proteins of acute myeloid leukemia. (2014) (51)
CEACAM1 (CD66a) Promotes Human Monocyte Survival via a Phosphatidylinositol 3-Kinase- and AKT-dependent Pathway* (2006) (50)
The interaction between CD300a and phosphatidylserine inhibits tumor cell killing by NK cells (2013) (49)
The Critical Role of Residues 43R and 44Q of Carcinoembryonic Antigen Cell Adhesion Molecules-1 in the Protection from Killing by Human NK Cells1 (2004) (49)
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy (2019) (49)
Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity (2020) (48)
CEACAM1 on activated NK cells inhibits NKG2D‐mediated cytolytic function and signaling (2013) (47)
A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors. (2013) (46)
Inflammatory monocytes and NK cells play a crucial role in DNAM-1–dependent control of cytomegalovirus infection (2016) (44)
Tumor Targeting by Fusobacterium nucleatum: A Pilot Study and Future Perspectives (2017) (42)
Expression of ligands to NKp46 in benign and malignant melanocytes. (2008) (41)
Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors. (2014) (41)
Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma (2016) (41)
MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10b (2014) (40)
Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules (2017) (40)
HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins (2016) (39)
MicroRNA based immunoevasion mechanism of human polyomaviruses (2011) (38)
MicroRNA Editing Facilitates Immune Elimination of HCMV Infected Cells (2014) (38)
Biological function of the soluble CEACAM1 protein and implications in TAP2‐deficient patients (2004) (38)
Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20 (2017) (36)
The Transmembrane Sequence of Human Histocompatibility Leukocyte Antigen (HLA)-C as a Determinant in Inhibition of a Subset of Natural Killer Cells (1999) (36)
Intracellular Cysteine Residues in the Tail of MHC Class I Proteins Are Crucial for Extracellular Recognition by Leukocyte Ig-Like Receptor 11 (2007) (36)
NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease (2014) (35)
The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB (2016) (35)
The Natural Cytotoxicity Receptor 1 Contribution to Early Clearance of Streptococcus pneumoniae and to Natural Killer-Macrophage Cross Talk (2011) (34)
HSV1 MicroRNA Modulation of GPI Anchoring and Downstream Immune Evasion (2016) (33)
Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells (2016) (32)
The Viral KSHV Chemokine vMIP-II Inhibits the Migration of Naive and Activated Human NK Cells by Antagonizing Two Distinct Chemokine Receptors (2013) (31)
Special organization of the HLA-G protein on the cell surface. (2003) (31)
CD100 on NK Cells Enhance IFNγ Secretion and Killing of Target Cells Expressing CD72 (2007) (31)
Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas. (1997) (30)
Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin (2007) (29)
HCMV vCXCL1 Binds Several Chemokine Receptors and Preferentially Attracts Neutrophils over NK Cells by Interacting with CXCR2. (2016) (29)
Cytokine secretion and NK cell activity in human ADAM17 deficiency (2015) (29)
Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in ‐cis: A lesson from NKp44 (2015) (28)
The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity (2016) (28)
H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire. (1992) (28)
CXCL 12 expression by invasive trophoblasts induces the specific migration of CD 16 human natural killer cells (2003) (27)
The Helicobacter pylori HopQ outermembrane protein inhibits immune cell activities (2019) (27)
Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency. (2005) (27)
Disarming Cellular Alarm Systems—Manipulation of Stress-Induced NKG2D Ligands by Human Herpesviruses (2017) (27)
The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study. (2007) (26)
IFNG-AS1 Enhances Interferon Gamma Production in Human Natural Killer Cells (2019) (26)
Human cytomegalovirus induces a distinct innate immune response in the maternal-fetal interface. (2015) (26)
Loss of kindlin-3 alters the threshold for NK cell activation in human leukocyte adhesion deficiency-III. (2012) (26)
Proteomic analysis of human natural killer cells: insights on new potential NK immune functions. (2005) (26)
Notch activation enhances IFNgamma secretion by human peripheral blood and decidual NK cells. (2010) (25)
Human leucocyte antigen-G and its recognition by natural killer cells. (1999) (25)
Immunorthodontics: in vivo gene expression of orthodontic tooth movement (2020) (25)
HSV-2 Specifically Down Regulates HLA-C Expression to Render HSV-2-Infected DCs Susceptible to NK Cell Killing (2013) (24)
Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency (2018) (24)
The Role of Natural Cytotoxicity Receptors in Various Pathologies: Emphasis on Type I Diabetes (2014) (23)
Comprehensive annotations of human herpesvirus 6A and 6B genomes reveal novel and conserved genomic features (2019) (23)
Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy (2008) (23)
The paired receptors TIGIT and DNAM-1 as targets for therapeutic antibodies. (2017) (22)
NKp46 regulates allergic responses (2013) (22)
RNA-binding proteins regulate the expression of the immune activating ligand MICB (2014) (22)
NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome. (2007) (22)
The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack (2018) (22)
Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells. (1995) (21)
Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes (2014) (21)
Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies (2021) (21)
Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1 (2018) (20)
CEACAM1-Mediated Inhibition of Virus Production (2016) (20)
Learning from experience: cellular and molecular bases for improved outcome in subsequent pregnancies. (2019) (20)
Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours (2017) (19)
The role of NK cells in innate immunity. (2000) (19)
Human trophectoderm apposition is regulated by interferon γ-induced protein 10 (IP-10) during early implantation. (2013) (19)
Manipulation of NK cytotoxicity by the IAP family member Livin (2007) (18)
Stromal Cell-Derived Factor 1 Mediates Immune Cell Attraction upon Urinary Tract Infection. (2017) (18)
Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity (2016) (18)
The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells (2018) (18)
N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors. (2000) (17)
Intercellular Transfer of Carcinoembryonic Antigen from Tumor Cells to NK Cells1 (2007) (17)
Fusobacterium nucleatum and cancer (2022) (16)
Fusobacterium nucleatum CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation (2021) (16)
Expression, Function, and Molecular Properties of the Killer Receptor Ncr1-Noé (2015) (16)
NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy (2017) (16)
NK‐cell receptors NKp46 and NCR1 control human metapneumovirus infection (2017) (15)
Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells. (2020) (15)
NK cell development in bone marrow and liver: site matters (2014) (15)
Altered dendritic cell–natural killer interaction in Kenyan sex workers resistant to HIV-1 infection (2012) (15)
The Expression of the Beta Cell-Derived Autoimmune Ligand for the Killer Receptor Nkp46 Is Attenuated in Type 2 Diabetes (2013) (14)
Recognition of Mycoplasma hyorhinis by CD99‐Fc molecule (2004) (14)
Interaction of the LILRB1 inhibitory receptor with HLA class Ia dimers (2016) (14)
Immune Changes Induced by Orthodontic Forces: A Critical Review (2021) (14)
Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression (2017) (14)
Battle of the midgets (2012) (13)
Pregnancy-specific glycoprotein expression in normal gastrointestinal tract and in tumors detected with novel monoclonal antibodies (2016) (13)
A phenotypic and functional characterization of NK cells in adenoids (2007) (12)
Molecular mechanisms of human herpes viruses inferring with host immune surveillance (2020) (12)
Involvement of CXCR 4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD / SCID mice (2003) (12)
The use of microRNA by human viruses: lessons from NK cells and HCMV infection (2014) (12)
The Association of MHC Class I Proteins with the 2B4 Receptor Inhibits Self-Killing of Human NK Cells (2010) (12)
Immunological assessment of familial tinea corporis (2008) (11)
Human anti‐NKp46 antibody for studies of NKp46‐dependent NK cell function and its applications for type 1 diabetes and cancer research (2019) (11)
Suppression of human metapneumovirus (HMPV) infection by the innate sensing gene CEACAM1 (2016) (11)
Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy (2004) (11)
The integrated stress response promotes B7H6 expression (2019) (11)
Expansion of CD16 positive and negative human NK cells in response to tumor stimulation (2014) (10)
Novel APC-like properties of human NK cells directly regulate T cell activation (2015) (10)
HLA-G complexes are observed on the cell surface. (2007) (10)
Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy (2008) (10)
Sweet Killers: NK Cells Need Glycolysis to Kill Tumors. (2018) (10)
Binding of the Fap 2 Protei n of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack Graphical (2015) (10)
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection (2021) (9)
Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion (2020) (9)
Placental colonization by Fusobacterium nucleatum is mediated by binding of the Fap2 lectin to placentally displayed Gal-GalNAc. (2022) (9)
A Unique Regulation Region in the 3′ UTR of HLA-G with a Promising Potential (2020) (8)
Vigilin Regulates the Expression of the Stress-Induced Ligand MICB by Interacting with Its 5′ Untranslated Region (2017) (8)
Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity (2015) (8)
Reduced KIR2DL1 Recognition of MHC Class I Molecules Presenting Phosphorylated Peptides1 (2006) (8)
Trans-well migration assay (2006) (7)
Expression and function of NKp46 W32R: the human homologous protein of mouse NKp46 W32R (Noé) (2017) (7)
A slowly cleaved viral signal peptide acts as a protein-integral immune evasion domain (2021) (7)
NCR1‐deficiency diminishes the generation of protective murine cytomegalovirus antibodies by limiting follicular helper T‐cell maturation (2017) (7)
Identification and Analysis of Natural Killer Cells in Murine Nasal Passages (2015) (7)
CD 11 c lo B 220 interferon-producing killer dendritic cells are activated natural killer cells (2007) (6)
“Messieurs, c'est les microbes qui auront le dernier mot”: Gentlemen, it is the microbes who have the last word (Louis Pasteur)—Fusobacterium nucleatum protect tumors from killing by immune cells (2015) (6)
Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL) (2018) (6)
Metastamir-mediated immune evasion (2013) (6)
Role of HLA-G in Viral Infections (2022) (6)
Methods to identify and characterize different NK cell receptors and their ligands. (2010) (6)
Decay of the Stress-Induced Ligand MICA Is Controlled by the Expression of an Alternative 3′ Untranslated Region (2018) (6)
Neisserial outer membrane vesicles bind the co-inhibitory receptor CEACAM 1 and suppress CD 4 + T lymphocyte function (2007) (5)
Faculty Opinions recommendation of Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancy. (2008) (5)
PILRα binds an unknown receptor expressed primarily on CD56bright and decidual-NK cells and activates NK cell functions (2016) (5)
CXCL 12 Expression by Invasive Trophoblasts Induces the Specific Migration of CD 16 Negative Human Natural Killer Cells (2003) (5)
Maternal adaptation to vasculogenesis and angiogenesis at the feto-maternal interface. (2005) (5)
The human cytomegalovirus protein UL147A downregulates the most prevalent MICA allele: MICA*008, to evade NK cell-mediated killing (2020) (5)
NK-92 cells retain vitality and functionality when grown in standard cell culture conditions (2022) (4)
Natural killer cells control metastasis via structural editing of primary tumors in mice (2019) (4)
Candida albicans evades NK cell elimination via binding of Agglutinin-Like Sequence proteins to the checkpoint receptor TIGIT (2022) (4)
Microenvironment and Immunology MiR-10 b Downregulates the Stress-Induced Cell Surface MoleculeMICB , a Critical Ligand for Cancer Cell Recognition by Natural Killer Cells (2012) (4)
The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune Recognition (2021) (3)
Receptors on NK cells (2010) (3)
Retracted Correction: CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma (1998) (3)
Faculty Opinions recommendation of Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. (2009) (3)
Obinutuzumab Activates CD64 More Potently Than Other Anti-CD20 Antibodies in Chronic Lymphocytic Leukemia (CLL) (2017) (3)
Altered NKp46 Recognition and Elimination of Influenza B Viruses (2020) (2)
Human Metapneumovirus Escapes NK Cell Recognition through the Downregulation of Stress-Induced Ligands for NKG2D (2020) (2)
MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination (2021) (2)
Anti-RhD antibody therapy modulates human natural killer cell function (2020) (2)
The inhibitory receptor CD300a is essential for neutrophil‐mediated clearance of urinary tract infection in mice (2020) (2)
Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins (2022) (2)
A BW Reporter System for Studying Receptor-Ligand Interactions. (2019) (2)
Cell Adhesion Molecule 1 NK Killing via Interaction with CEA-Related Carcinoembryonic Antigen ( CEA ) Inhibits (2005) (2)
Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern (2022) (1)
NK-Activating Receptor KIR 2 DS 4 MHC Class I-Independent Recognition of Drize (2004) (1)
66 – Immunogenicity of Human Embryonic Stem Cells (2004) (1)
Targeting PVR (CD155) and its receptors in anti-tumor therapy (2018) (1)
Editorial introduction for Seminars in Immunopathology special issue on “Immune modulation, properties and models of CMV” (2014) (1)
5A.1 When killers become builders: The role of NK cells in human placental development (2007) (1)
CEACAM1 Activation by CbpF-Expressing E. coli (2021) (1)
Human cytomegalovirus miRNAs (2011) (1)
Retraction. Novel APC-like properties of human NK cells directly regulate T cell activation. (2015) (1)
The use of microRNA by human viruses: lessons from NK cells and HCMV infection (2014) (1)
Natural Killer Cells at the Tumors Microenvironment (2008) (1)
Quantification of Bacterial Attachment to Tissue Sections. (2018) (1)
NK Cells Under Hypoxia: The Two Faces of Vascularization in Tumor and Pregnancy (2022) (1)
Human NK Cells Molecules-1 in the Protection from Killing by Carcinoembryonic Antigen Cell Adhesion Q of 44 R and 43 The Critical Role of Residues (2004) (1)
Tumor-Associated Antigen Peptides as Anti-Metastatic Vaccines (2004) (1)
Novel approach to identify putative Epstein–Barr–virus microRNAs regulating host cell genes with relevance in tumor biology and immunology (2022) (0)
The integrated stress response promotes B7H6 expression (2019) (0)
The NK killer receptor Ncr1 shapes tumor architecture to prevent metastasis (2015) (0)
Author response: The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB (2016) (0)
254 NTX-1088, a potent anti-PVR Mab induces DNAM1-mediated antitumor immunity (2021) (0)
36 Gene and peptide therapy of tumor metastases in murine models (1995) (0)
Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (2022) (0)
Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression (2017) (0)
Carcinoembryonic Antigen Cell Adhesion Molecules-1 in the Protection from Killing by Human NK Cells (2004) (0)
TUMOR VARIABILITY AND SENSITIVITY TO T AND NK CELLS : IMPLICATIONS FOR CANCER IMMUNOTHERAPY (1999) (0)
Killing of Avian and Swine Inﬂuenza Virus by Natural Killer Cells (cid:1) (2010) (0)
Imunološki mehanizam nastanka upale visceralnog masnog tkiva u debljini kao podloge razvoja šećerne bolesti tipa 2 i njezinih kliničkih komplikacija (2016) (0)
with an Intracellular Bacterium Lysis of Mononuclear Phagocytes Infected The NKp46 Receptor Contributes to NK Cell (2002) (0)
LPS or get killed (2007) (0)
Intestinal Immune Defense against Dispensable for IL-22-Mediated Innate The Natural Cytotoxicity Receptor NKp 46 Is (2009) (0)
Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20 (2017) (0)
Abstract 6657: Phase I trial of first-in-class anti-PVR mAb NTX1088: Restoration of DNAM1 expression as MOA for enhanced antitumor immunity (2023) (0)
Viral regulation of PVR reveals robust capacity of DNAM-1 in cytomegalovirus control by NK cells and macrophages (2015) (0)
Faculty Opinions recommendation of Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. (2008) (0)
Essential for Optimal Peptide Loading Antigen Processing-Associated Complex Is Tapasin into the Transporter Associated with Recruitment of MHC Class I Molecules by (2002) (0)
Function of HCMV derived chemokines on NK cells (IRC4P.614) (2015) (0)
Expression Profiling Immunological Modalities Revealed by Gene Novel Insights on Human NK Cells' (2004) (0)
MYELOID NEOPLASIA Immune evasion by oncogenic proteins of acute myeloid leukemia (2014) (0)
Abstract P102: NTX-1088, A potent first-in-class, anti-PVR mAb, restores expression and function of DNAM1 for optimal DNAM1-mediated antitumor immunity (2021) (0)
Gene therapy and peptide therapy of tumor metastasis (2007) (0)
Abstract 5534: NTX-1088, a first-in-class anti-PVR mAb mediates DNAM1-dependent antitumor immunity (2022) (0)
Abstract PO001: Preclinical activity of glypican-3 (GPC3) and NKp46 directed FLEX-NK™ engager antibody (CYT-303) in combination with iPSC derived natural killer cells (iNKs) or peripheral blood (PB) NK cells in hepatocellular carcinoma (HCC) (2022) (0)
NK cells in TAP2-deficient patients Functional aberrant expression of CCR2 receptor on chronically activated (2013) (0)
Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy (2008) (0)
migration of CD16 negative human natural killer cells CXCL12 expression by invasive trophoblasts induces the specific (2013) (0)
Lung Clearance Assay (2013) (0)
Viral downregulation of CD155 reveals strong effect of DNAM-1 in virus control by NK cells and macrophages (2015) (0)
A double-edged sword - the role of human ADAM17 in NK cell activity (2017) (0)
CEACAM 1-Mediated Inhib ition of Virus Production Graphical Abstract Highlights (0)
Natural Cytotoxicity Receptors and MHC Initiating Cells : A Role for − Colon Cancer Human NK Cells Selective Targeting of Dieli (2013) (0)
The Immune Mechanisms of the Visceral Adipose Tissue Inflammation in Obesity as the Underlying Cause of Development of Diabetes Mellitus Type 2 and its Complication (2014) (0)
Correction: Novel Insights on Human NK Cells’ Immunological Modalities Revealed by Gene Expression Profiling (2015) (0)
Abstract P075: NTX-1088, a potent first-in-class, anti-PVR mAb, restores expression and function of DNAM1 for optimal DNAM1-mediated antitumor immunity (2022) (0)
Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells. (2023) (0)
Homophilic Carcinoembryonic Cell Adhesion Lymphocyte Effector Functions by the Inhibition of Human Tumor-Infiltrating (2006) (0)
Control LPS or get killed (2007) (0)
HLA-G Molecules 2 β Distinguishes between Conformed and The CD 85 J / Leukocyte Inhibitory Receptor-1 Yagel and (2005) (0)
First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity (2022) (0)
Virus-mediated inhibition of natural cytotoxicity receptor recognition (2012) (0)
JEG3 transplantation assay (2006) (0)
High mannose level in bladder cancer enhances type 1 fimbria–mediated attachment of uropathogenic E. coli (2022) (0)
Decidual NK cells remember pregnancy (2014) (0)
Preparation and culture of cytotrophoblasts (2006) (0)
Dendritic cells are required for the expansion of viral-specific cytotoxic, IFN-gamma-secreting, CD8+ CTL in vitro (2006) (0)
Corrigendum (2018) (0)
Author response: Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion (2019) (0)
Editorial introduction for Seminars in Immunopathology special issue on “Immune modulation, properties and models of CMV” (2014) (0)
Stimulation of MHC class I binding receptors on decidual NK clones. (2006) (0)
756P Glypican-3 (GPC3) and NKp46 directed FLEX-NK engager antibody (CYT-303) recruits natural killer (NK) cells to tumors in a preclinical hepatocellular carcinoma (HCC) mouse model (2022) (0)
1569: BCG Resistant Bladder Urothelial Carcinoma Under-Expresses Ligands for Natural Cytotoxicity Receptors of Natural Killer Cells (2007) (0)
P-13 Novel CEACAM1-based approach in melanoma immunotherapy (2007) (0)
Antigen from Tumor Cells to NK Cells Intercellular Transfer of Carcinoembryonic (2007) (0)
Microarray analysis of highly purified human decidual NK cells (2006) (0)
Human NK Cells with the 2 B 4 Receptor Inhibits Self-Killing of The Association of MHC Class I Proteins (2010) (0)
cells by NKp46 The mechanisms controlling the recognition of tumor and virus infected (2013) (0)
Cell Recognition of Candida glabrata through Binding of NKp 46 and NCR 1 to Fungal Ligands Epa 1 , Epa 6 , and Epa 7 Graphical (0)
Abstract 2752: Preclinical characterization of FLEX-NK࣪ tetravalent NKp46 engager directed against GPC3 (CYT-303) alone or in combination with iPSC derived Natural Killer cells (iNKs) against hepatocellular carcinoma (HCC) (2022) (0)
Abstract 5893: Suppression of anti-tumor immunity by the Fusobacterium nucleatum protease fusolisin (2023) (0)
Receptor NKp 46 / NCR 1 Tumors in the Absence of the NK-Activating Enhanced In Vivo Growth of Lymphoma (2009) (0)
Cells That Await Pregnancy Endometrial NK Cells Are Special Immature (2008) (0)
CellsExpression and Function of CD300 in NK (2010) (0)
P842: NOVEL MULTIFUNCTIONAL TETRAVALENT CD38 NKP46 FLEX-NK ENGAGERS ACTIVELY TARGET AND KILL MULTIPLE MYELOMA CELLS (2022) (0)
134. Molecular and functional memory in decidual NK cells of parous women (2018) (0)
Brahmaraju Mopidevi , Madhusudhan Ponnala and Ashok Kumar binding modulates its gene expression through microRNA Human angiotensinogen + 11525 C / A polymorphism (2013) (0)
474 First-in-class anti-PVR mAb NTX1088 restores expression of DNAM1 and augments antitumor immunity (2022) (0)
Pregnancy recall in decidual NK cells (2014) (0)
Functional Aberrant Expression of CCR2 Receptor on Chronically Activated NK Cells in TAP2-Deficient Patients (2005) (0)
TIGIT therapy for cancer treatment – TIGITtherapy – ERC (2018) (0)
Do decidual NK cells remember pregnancy? A possible explanation for preeclampsia risk in primiparity and primipaternity (2017) (0)
Faculty Opinions recommendation of Effector functions of human decidual NK cells in healthy early pregnancy are dependent on the specific engagement of natural cytotoxicity receptors. (2009) (0)
Isolation of human NK subsets (2006) (0)
''Cytomegalovirus downregulation of PVR reveals strong effect of DNAM-1 in virus control by NK cells and macrophages'' (2015) (0)
Receptor-1 Function Surface Are Important for Leukocyte Ig-Like Complexes of HLA-G Protein on the Cell (2003) (0)
Extracellular Recognition by Leukocyte MHC Class I Proteins Are Crucial for Intracellular Cysteine Residues in the Tail of (2013) (0)
Abstract 3436: Novel multifunctional tetravalent CD38 NKp46 FLEX NK࣪ engagers actively target and kill multiple myeloma cells (2022) (0)
Tumor-associated antigen peptides as anti-metastatic vaccines (1998) (0)
MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination (2022) (0)
Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3 (2023) (0)
Use of NKp46 to prevent type I diabetes (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ofer Mandelboim?

Ofer Mandelboim is affiliated with the following schools:

Ofer Mandelboim's Academic­Influence.com Rankings

Ofer Mandelboim's Degrees

Similar Degrees You Can Earn

Why Is Ofer Mandelboim Influential?

Ofer Mandelboim's Published Works

Published Works

What Schools Are Affiliated With Ofer Mandelboim?

Ofer Mandelboim's AcademicInfluence.com Rankings